Shandong Sito Bio-technology Co (SZSE:300583) EPS (Basic) : ¥-0.64 (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Shandong Sito Bio-technology Co EPS (Basic)?

Shandong Sito Bio-technology Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥-0.15. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.64.

Shandong Sito Bio-technology Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥-0.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.64.

Shandong Sito Bio-technology Co's EPS without NRI for the three months ended in Mar. 2025 was ¥-0.12. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.28.

During the past 12 months, Shandong Sito Bio-technology Co's average EPS without NRIGrowth Rate was -346.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Shandong Sito Bio-technology Co's highest 3-Year average EPS without NRI Growth Rate was 33.90% per year. The lowest was -40.90% per year. And the median was -28.20% per year.

Shandong Sito Bio-technology Co EPS (Basic) Historical Data

The historical data trend for Shandong Sito Bio-technology Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sito Bio-technology Co EPS (Basic) Chart

Shandong Sito Bio-technology Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-1.05

0.21

0.24

0.25

-0.47

Shandong Sito Bio-technology Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.02	0.05	0.01	-0.55	-0.15

Shandong Sito Bio-technology Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shandong Sito Bio-technology Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-88.767	-	0)	/	188.865
	=	-0.47

Shandong Sito Bio-technology Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-27.509	-	0)	/	183.390
	=	-0.15

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.64

Shandong Sito Bio-technology Co (SZSE:300583) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Shandong Sito Bio-technology Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Shandong Sito Bio-technology Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Sito Bio-technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Sito Bio-technology Co Ltd (SZSE:300583) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

South Section of East Outer Ring Road, Dingtao District, Shandong Province, Heze, CHN, 274100

Website

http://www.sitobiotech.com

Shandong Sito Bio-technology Co Ltd is a biotechnology company. It uses genetic engineering technology and microbial transformation technology to develop and produce steroid drug raw materials, specialty respiratory raw materials and finished preparations, and other drug intermediaries. The company operates in the following business segments; intermediates, high-end specialty respiratory APIs, and preparations. Its product offerings include androstenedione (AD), 9-hydroxy androstenedione (90H-AD), 17a-hydroxyprogesterone derivatives (A ring), and bi-decanoic acid (BA), and others. In addition, the company holds patents for various APIs and other intermediaries.

Executives

Mi Qi	Directors, executives
Wang Min	Director
Kong Qing Zhi	Executives
He Jian Yong	Directors, executives
Ceng Qing Li	Securities Affairs Representative

Shandong Sito Bio-technology Co Headlines

No Headlines